David Capper

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 349 publications

Exploring the landscape of targetable alterations in patients with glioblastoma.

Exploring the landscape of targetable alterations in patients with glioblastoma.

Journal: Nature reviews. Clinical oncology
Published: July 20, 2026

Sellar region neurocytomas exhibit a CIMP and neuroendocrine-like epigenetic signature distinct from other intra-axial neurocytomas.

Sellar region neurocytomas exhibit a CIMP and neuroendocrine-like epigenetic signature distinct from other intra-axial neurocytomas.

Journal: Acta neuropathologica
Published: July 02, 2026

Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

Journal: Klinische Padiatrie
Published: June 24, 2026

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

Journal: Acta neuropathologica communications
Published: June 02, 2026

Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Author Correction: A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Journal: Nature cell biology
Published: April 28, 2026

Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.

Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.

Journal: Acta neuropathologica communications
Published: April 17, 2026

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting.

Journal: Brain pathology (Zurich, Switzerland)
Published: March 13, 2026

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Loss of meningothelial identity and mesenchymal fate switching in NF2-mutant meningiomas.

Journal: Acta neuropathologica
Published: February 21, 2026

Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.

Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.

Journal: Neuro-oncology
Published: January 19, 2026

Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.

Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.

Journal: Neuro-oncology
Published: January 19, 2026

Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Journal: Cancers
Published: December 23, 2025

Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort.

Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort.

Journal: Acta neuropathologica communications
Published: December 23, 2025
Showing 1-12 of 349

Last Updated: 09/26/2026